Actively Recruiting

Phase Not Applicable
Age: 14Years - 16Years
All Genders
NCT05910840

Support-t Online Training in Youth Living With Type 1 Diabetes Transitioning to Adult Care

Led by Anne-Sophie Brazeau · Updated on 2025-09-25

200

Participants Needed

4

Research Sites

155 weeks

Total Duration

On this page

Sponsors

A

Anne-Sophie Brazeau

Lead Sponsor

M

McGill University Health Centre/Research Institute of the McGill University Health Centre

Collaborating Sponsor

AI-Summary

What this Trial Is About

The investigators will conduct a randomized controlled trial (RCT) to examine how an online training and peer support platform could help the preparation to transition to adult care. Among 14-16 year old youth with Type 1 Diabetes (T1D), the investigators aim to assess the effect of an online training and peer support platform (Support-t) integrated in usual care, compared with usual care on Hemoglobin A1c (HbA1c), adverse outcomes and psychosocial measures during the preparation for transition to adult care. The investigators will conduct a multi-site, parallel group, blinded (outcome assessors, data analysts), superiority RCT of adolescents with T1D (14-16 years of age) followed at one of 4 university teaching hospital-based pediatric diabetes clinics in the province of Quebec.

CONDITIONS

Official Title

Support-t Online Training in Youth Living With Type 1 Diabetes Transitioning to Adult Care

Who Can Participate

Age: 14Years - 16Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adolescents with a clinical diagnosis of Type 1 Diabetes
  • Aged 14 to 16 years
  • Receiving diabetes care at one of four university teaching hospital-based pediatric diabetes clinics in Quebec: Montreal Children's Hospital-McGill University Health Centre, Centre hospitalier universitaire de Sherbrooke, Le Copain-Hôpital de Gatineau, Centre Hospitalier Universitaire de Québec
  • Have access to the internet
  • Have an active email address
  • Fluent in English or French
Not Eligible

You will not qualify if you...

  • Severe neurocognitive disabilities
  • Conditions associated with shortened erythrocyte survival, such as hemolytic anemia or other conditions causing inaccurate Hemoglobin A1c (HbA1c) measurements

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 4 locations

1

Clinique de pédiatrie Le Copain-Hôpital de Gatineau

Gatineau, Canada

Not Yet Recruiting

2

Montreal Children's Hospital - McGill University Health Centre

Montreal, Canada

Actively Recruiting

3

Centre Hospitalier Universitaire de Québec

Québec, Canada

Not Yet Recruiting

4

Centre Hospitalier Universitaire de Sherbrooke

Sherbrooke, Canada

Not Yet Recruiting

Loading map...

Research Team

A

Anne-Sophie Brazeau, PhD

CONTACT

A

Amelie Roy-Fleming, MSc

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here